Among the proven prognostic markers, the most important indicators are the stage of the disease, the patient’s age, the tumor’s histological grade, as well as expression of estrogen receptors (ER), progesterone receptors (PR), the percentage of Ki-67-positive tumor cells, and the expression of mutant p53 oncoprotein2. Here, PGR is linked to neoplasm.